Search This Blog

Friday, October 2, 2026

Eli Lilly wins FDA approval for Jaypirca as first-line treatment for certain leukemias

 

Eli Lilly wins FDA approval for Jaypirca as first-line treatment for certain adults with previously untreated CLL/SLL without 17p deletion

  • Approval expands Jaypirca's U.S. label and potential market in chronic lymphocytic leukemia and small lymphocytic lymphoma.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)